Christina Mansour: Shifting Aortic Stenosis Care Toward a Lifetime Management Strategy
Christina Mansour, Cardiology Fellow at UC Irvine shared a post on LinkedIn about a recent article she and her colleagues co-authored, adding:
“Thrilled to share my first post on LinkedIn with our recently published review paper in the Journal of Clinical Medicine (JCM):
‘Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making.’
In this review, we describe the evolving paradigm of aortic stenosis management toward a lifetime strategy that extends beyond the initial procedure.
We highlight the importance of index valve selection, guided by clinical and anatomic factors as well as future re-intervention planning, to achieve durable long-term outcomes.
Grateful to my co-authors for their collaboration and support! Long-Co Nguyen, Fabio Sagebin, and Antonio H. Frangieh.
Thank you Dr. Antonio H. Frangieh, for the opportunity to contribute to this important area of research and for all your incredible mentorship!”
Title: Lifetime Management of Aortic Stenosis: Evolving Strategies and Personalized Decision-Making
Authors: Christina M. Mansour, Long-Co L. Nguyen, Fabio Sagebin, Antonio H. Frangieh
Read the Full Article on JCM
Stay updated with Hemostasis Today.
-
Apr 15, 2026, 04:52Ulrich Pecks: Personalized Approaches to VTE Prevention in Pregnant Women with Inherited Thrombophilia
-
Apr 15, 2026, 04:06Brenda Pleasant: Insights from the HFA Symposium on Hemophilia Care
-
Apr 15, 2026, 03:43Lexy Halloran: Addressing Diagnostic Inequities in Women with Chronic Conditions
-
Apr 14, 2026, 17:32Denise M.: Surviving Sepsis 2026 – The Upstream Revolution
-
Apr 14, 2026, 17:23Meghanath Yenni։ What’s New in Acute Ischemic Stroke in 2026
-
Apr 14, 2026, 17:11Phil Spinella: What Dose of TXA for Children With Severe Traumatic Bleeding Should You Use?
-
Apr 14, 2026, 17:08Abdulrahman Katib: How Endovascular Stenting Is Transforming the Treatment of Severe PTS
-
Apr 14, 2026, 17:00Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
-
Apr 14, 2026, 16:58Ney Carter Borges: NLRP3 Inhibition in Atherosclerosis – Early Clinical Signal Beyond Lipids